• Iron Path Capital acquired Boulder Scientific Company from Quad-C Management on November 11, 2026.
• The acquisition marks the first investment from its $450 million Fund II.
• Boulder Scientific manufactures high-performance organometallic compounds and provides complex synthetic chemistry services across two Colorado facilities.
• The partnership will support investment in Boulder Scientific's capabilities and expansion into existing and new end markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iron Path Capital LP published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.